| Ticker Details |
STAAR Surgical Company
Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses and delivery systems for the eye. The Company develops, produces, and markets intraocular lenses.
|
| IPO Date: |
March 2, 1992 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$876.74M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.56 | 2.46%
|
| Avg Daily Range (30 D): |
$0.44 | 2.31%
|
| Avg Daily Range (90 D): |
$0.61 | 2.60%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.29M |
| Avg Daily Volume (30 D): |
1.25M |
| Avg Daily Volume (90 D): |
1.2M |
| Trade Size |
| Avg Trade Size (Sh.): |
80 |
| Avg Trade Size (Sh.) (30 D): |
66 |
| Avg Trade Size (Sh.) (90 D): |
76 |
| Institutional Trades |
| Total Institutional Trades: |
3,819 |
| Avg Institutional Trade: |
$2.71M |
| Avg Institutional Trade (30 D): |
$1.9M |
| Avg Institutional Trade (90 D): |
$1.92M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.35M |
| Avg Closing Trade (30 D): |
$2.26M |
| Avg Closing Trade (90 D): |
$2.39M |
| Avg Closing Volume: |
72K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.96
|
$.18
|
$-.34
|
|
Diluted EPS
|
$-1.95
|
$.18
|
$-.34
|
|
Revenue
|
$230.59M
|
$94.73M
|
$44.32M
|
|
Gross Profit
|
$170.33M
|
$77.88M
|
$32.8M
|
|
Net Income / Loss
|
$-96.37M
|
$8.88M
|
$-16.81M
|
|
Operating Income / Loss
|
$-96.79M
|
$18.49M
|
$-29.96M
|
|
Cost of Revenue
|
$60.26M
|
$16.86M
|
$11.52M
|
|
Net Cash Flow
|
$12.15M
|
$9.02M
|
$-5.98M
|
|
PE Ratio
|
|
|
|
|
|
|